ICD-10-CM Code D07.0

Carcinoma in situ of endometrium

Version 2020 Billable Code Diagnoses For Females Only Neoplasm CaInSitu

Valid for Submission

D07.0 is a billable code used to specify a medical diagnosis of carcinoma in situ of endometrium. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code D07.0 might also be used to specify conditions or terms like carcinoma in situ of body of uterus, carcinoma in situ of endometrium, carcinoma in situ of isthmus of uterus, carcinoma in situ of myometrium, carcinoma in situ of placenta, carcinoma in situ of uterus, etc

The code D07.0 is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.

The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: corpus uteri ; corpus uteri isthmus ; endometrium (gland) (stroma) ; fetal membrane ; fundus uterus ; isthmus uteri ; myometrium ; etc

ICD-10:D07.0
Short Description:Carcinoma in situ of endometrium
Long Description:Carcinoma in situ of endometrium

Code Edits

The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:

  • Diagnoses for females only - Medicare Code Editor detects inconsistencies between a patient’s sex and any diagnosis on the patient’s record, this code applies to FEMALES only .

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Carcinoma in situ of body of uterus
  • Carcinoma in situ of endometrium
  • Carcinoma in situ of isthmus of uterus
  • Carcinoma in situ of myometrium
  • Carcinoma in situ of placenta
  • Carcinoma in situ of uterus
  • Neoplasm of isthmus of uterus
  • Tis

Diagnostic Related Groups

The ICD-10 code D07.0 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2020 through 09/30/2020.

  • 736 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC
  • 737 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC
  • 738 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC
  • 739 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC
  • 740 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC
  • 741 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC

Convert D07.0 to ICD-9

  • 233.2 - Ca in situ uterus NEC (Approximate Flag)

Code Classification

  • Neoplasms (C00–D48)
    • In situ neoplasms (D00-D09)
      • Carcinoma in situ of other and unspecified genital organs (D07)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Table of Neoplasms

The code D07.0 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»corpus
  »uteri
C54.9C79.82D07.0D26.1D39.0D49.59
»corpus
  »uteri
    »isthmus
C54.0C79.82D07.0D26.1D39.0D49.59
»endometrium (gland) (stroma)
C54.1C79.82D07.0D26.1D39.0D49.59
»fetal membrane
C58C79.82D07.0D26.7D39.2D49.59
»fundus
  »uterus
C54.3C79.82D07.0D26.1D39.0D49.59
»isthmus uteri
C54.0C79.82D07.0D26.1D39.0D49.59
»myometrium
C54.2C79.82D07.0D26.1D39.0D49.59
»placenta
C58C79.82D07.0D26.7D39.2D49.59
»stroma, endometrial
C54.1C79.82D07.0D26.1D39.0D49.59
»uterus, uteri, uterine
C55C79.82D07.0D26.9D39.0D49.59
»uterus, uteri, uterine
  »body
C54.9C79.82D07.0D26.1D39.0D49.59
»uterus, uteri, uterine
  »cornu
C54.9C79.82D07.0D26.1D39.0D49.59
»uterus, uteri, uterine
  »corpus
C54.9C79.82D07.0D26.1D39.0D49.59
»uterus, uteri, uterine
  »endometrium
C54.1C79.82D07.0D26.1D39.0D49.59
»uterus, uteri, uterine
  »fundus
C54.3C79.82D07.0D26.1D39.0D49.59
»uterus, uteri, uterine
  »isthmus
C54.0C79.82D07.0D26.1D39.0D49.59
»uterus, uteri, uterine
  »lower segment
C54.0C79.82D07.0D26.1D39.0D49.59
»uterus, uteri, uterine
  »myometrium
C54.2C79.82D07.0D26.1D39.0D49.59

Information for Patients


Uterine Cancer

The uterus, or womb, is the place where a baby grows when a women is pregnant. There are different types of uterine cancer. The most common type starts in the endometrium, the lining of the uterus. This type is also called endometrial cancer.

The symptoms of uterine cancer include

  • Abnormal vaginal bleeding or discharge
  • Trouble urinating
  • Pelvic pain
  • Pain during intercourse

Uterine cancer usually happens after menopause. It is more common in women who have obesity. You also have a higher risk if you took estrogen-only hormone replacement therapy (menopausal hormone therapy) for many years.

Tests to find uterine cancer include a pelvic exam, imaging tests, and a biopsy. The most common treatment is a hysterectomy, which is surgery to remove the uterus. Sometimes the surgery also removes the ovaries and fallopian tubes. Other treatments include hormone therapy, radiation therapy, and chemotherapy. Some women get more than one type of treatment.

NIH: National Cancer Institute


[Learn More]